LEPROSY REVIEW

Scope & Guideline

Connecting researchers to combat leprosy effectively.

Introduction

Delve into the academic richness of LEPROSY REVIEW with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0305-7518
PublisherLEPRA
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1945 to 1948, from 1950 to 2024
AbbreviationLEPROSY REV / Lepr. Rev.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND

Aims and Scopes

The journal 'LEPROSY REVIEW' primarily aims to disseminate research findings and advancements in the understanding and management of leprosy, also known as Hansen's disease. It emphasizes a multidisciplinary approach, integrating clinical, epidemiological, social, and psychological aspects to enhance the care and quality of life for those affected by the disease.
  1. Epidemiological Research:
    Focuses on the trends, patterns, and determinants of leprosy in various populations, including studies on incidence, prevalence, and factors influencing disease transmission.
  2. Clinical Management and Treatment:
    Explores various treatment modalities, including multi-drug therapy (MDT), new drug developments, and management of leprosy-related complications and adverse effects.
  3. Psychosocial Aspects of Leprosy:
    Investigates the stigma, discrimination, and mental health challenges faced by individuals affected by leprosy, aiming to improve their social integration and quality of life.
  4. Innovative Diagnostic and Therapeutic Techniques:
    Covers advancements in diagnostic methodologies, including molecular techniques and imaging, as well as novel therapeutic approaches and self-care practices.
  5. Health System Strengthening:
    Discusses capacity building among healthcare providers, improving access to care, and enhancing community awareness regarding leprosy.
Recent publications in 'LEPROSY REVIEW' indicate a notable shift towards addressing contemporary issues in leprosy management and care, reflecting the evolving landscape of public health and patient needs.
  1. Digital Health Innovations:
    An emerging focus on the application of digital technologies in leprosy care, including telemedicine and mobile health applications, reflects a response to the challenges posed by the COVID-19 pandemic.
  2. Social Determinants of Health:
    Increasing attention is being given to the social and economic factors affecting individuals with leprosy, highlighting the need for comprehensive approaches that address both health and social issues.
  3. Long-term Complications and Rehabilitation:
    There is a growing trend in studying the long-term effects of leprosy, including rehabilitation strategies and the management of disabilities resulting from the disease.
  4. Community Engagement and Stigma Reduction:
    Research focusing on community perceptions, stigma, and the integration of leprosy patients into society is gaining prominence, underlining the importance of social acceptance and support.
  5. Adherence to Treatment and Patient Education:
    Emerging themes include factors influencing treatment adherence and the effectiveness of educational programs aimed at improving knowledge and self-care among patients.

Declining or Waning

While 'LEPROSY REVIEW' continues to cover a wide array of topics, certain themes are becoming less prominent in recent publications. This may reflect shifting priorities in research funding, emerging challenges in leprosy management, or a broader focus on new methodologies.
  1. Historical Perspectives on Leprosy:
    There appears to be a reduction in papers focusing on the historical context and past treatments of leprosy, as the journal shifts towards current clinical practices and emerging challenges.
  2. Basic Biological Research:
    Research primarily focused on the basic biology of Mycobacterium leprae and related pathogens is less frequently published, possibly due to a shift towards applied research that directly impacts patient care.
  3. Geographical Case Studies:
    Fewer case studies detailing specific geographical leprosy outbreaks or localized patterns are being published, indicating a potential move towards broader epidemiological analyses instead.

Similar Journals

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Empowering skin health through groundbreaking research.
Publisher: MOSBY-ELSEVIERISSN: 0190-9622Frequency: 12 issues/year

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, published by Mosby-Elsevier, stands at the forefront of dermatological research and education. With an impressive impact factor and categorized as Q1 in Dermatology, this journal has established itself as a pivotal resource for healthcare professionals and researchers in the field. Since its inception in 1979, it has provided a platform for high-quality peer-reviewed articles, contributing significantly to advancements in dermatological science and practice through 2024. The journal commands an honorable position, ranking #8 out of 142 in the Scopus database's medicine dermatology category, placing it in the 94th percentile among its peers. Readers can access a wealth of cutting-edge studies, case reports, and reviews that address a broad spectrum of topics, from clinical dermatology to emerging therapies. In addition, the journal's commitment to excellence ensures it remains an essential tool for students, clinicians, and researchers dedicated to improving skin health and furthering knowledge in dermatology.

Pediatria-Asuncion

Empowering pediatric healthcare through innovative research.
Publisher: SOC PARAGUAYA PEDIATRIAISSN: 1683-979XFrequency: 3 issues/year

Pediatria-Asuncion is a prestigious journal dedicated to advancing the field of pediatrics, published by the SOC PARAGUAYA PEDIATRIA. Since its inception in 2005, this Open Access journal has provided a vital platform for the dissemination of research, clinical insights, and innovations in pediatric health, ensuring that findings are accessible to a global audience. With an ISSN of 1683-979X and an E-ISSN of 1683-9803, Pediatria-Asuncion is positioned to facilitate knowledge sharing among researchers, practitioners, and students in the medical community. Although specific metrics like HIndex and Scopus ranks are currently not available, the journal's commitment to quality content defines its importance in shaping pediatric healthcare practices, particularly within the vibrant academic landscape of Paraguay. For those seeking to contribute to and learn from cutting-edge pediatric research, Pediatria-Asuncion stands out as a key resource.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Cultivating a Legacy of Medical Excellence Since 1961
Publisher: ELSEVIER TAIWANISSN: 0929-6646Frequency: 1 issue/year

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

JOURNAL OF INFECTION AND CHEMOTHERAPY

Unveiling Innovations in Infection and Pharmacotherapy
Publisher: ELSEVIERISSN: 1341-321XFrequency: 6 issues/year

JOURNAL OF INFECTION AND CHEMOTHERAPY, published by Elsevier, is a leading journal in the fields of Infectious Diseases, Microbiology, and Pharmacology. With a solid reputation reflected in its prestigious Q2 ranking in Infectious Diseases and Pharmacology, and Q3 in Microbiology (medical), this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and prevention of infectious diseases. The journal provides a platform for high-quality, peer-reviewed scholarly articles, making it an essential reference point in the medical community. Despite being published without open access, it continues to attract significant scholarly attention, as denoted by its rankings in Scopus, which showcases its impact within the academic landscape. With a timeline converging from 1995 to 2024, JOURNAL OF INFECTION AND CHEMOTHERAPY is dedicated to advancing knowledge and contributing to better health outcomes globally.

AIDS Research and Treatment

Connecting research to real-world impact.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Indian Journal of Dermatology Venereology & Leprology

Elevating Standards in Dermatological and Venereological Research
Publisher: SCIENTIFIC SCHOLAR LLCISSN: 0378-6323Frequency: 6 issues/year

The Indian Journal of Dermatology Venereology & Leprology (IJDL) is a premier open-access journal dedicated to the fields of dermatology, venereology, and leprology, published by SCIENTIFIC SCHOLAR LLC since 2004. With a rich historical background dating back to 1976, the journal has established itself as a reputable source for high-quality research and clinical advancements in these disciplines. The IJDL is recognized for its academic rigor, boasting a 2023 category quartile ranking of Q2 in Dermatology and Q3 in Infectious Diseases, indicating its significant contribution to these fields. With an accessible online platform, researchers, practitioners, and students alike can readily explore the latest studies, case reports, and reviews that address key issues affecting public health, particularly in India and beyond. The journal serves not only as a repository of valuable knowledge but also as a vital forum for the exchange of ideas, fostering collaboration and innovation among professionals dedicated to enhancing skin health and combating infectious diseases.

International Journal of Mycobacteriology

Leading the charge in mycobacteriology research and treatment.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-5531Frequency: 4 issues/year

International Journal of Mycobacteriology is a peer-reviewed, open-access journal published by Wolters Kluwer Medknow Publications that specializes in the field of infectious diseases with a particular emphasis on mycobacterial research. Since its inception in 2012, this journal has emerged as a vital resource for researchers, healthcare professionals, and students aimed at advancing understanding and treatment of mycobacterial infections, including tuberculosis. With the journal being indexed in Scopus and holding a Q3 ranking in both Infectious Diseases and Microbiology (medical) for 2023, it reflects a substantial contribution to scholarly discourse in these domains, despite its current ranking positioning. Authors and readers benefit from the open access model, ensuring widespread dissemination of research findings and fostering collaboration across the global health community. Located in Mumbai, India, the journal continues to thrive with a commitment to quality research and innovation, welcoming contributions that further the exploration of mycobacteriology throughout the converged years from 2012 to 2024.

INDIAN JOURNAL OF MEDICAL RESEARCH

Empowering researchers to shape the future of healthcare.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0971-5916Frequency: 12 issues/year

INDIAN JOURNAL OF MEDICAL RESEARCH, published by Wolters Kluwer Medknow Publications, is a premier open-access journal that has been contributing to the field of medical research since its inception in 1945. With an E-ISSN of 0971-5916, this journal is dedicated to advancing the understanding of various medical disciplines, including biochemistry, genetics, and general medicine, as reflected in its 2023 Q2 category rankings across multiple fields. This journal is highly regarded for its rigorous peer-review process and impactful contributions, holding a notable impact factor that enhances its visibility and significance within the scientific community. As a key platform for disseminating original research and fostering collaboration among researchers, professionals, and students, the INDIAN JOURNAL OF MEDICAL RESEARCH is essential for anyone engaged in the exploration of health sciences in India and beyond. This open-access model, adopted since 2006, ensures that a broad audience can freely access valuable knowledge and findings, thereby promoting greater awareness and advancement in medical research.

Asian Biomedicine

Empowering Innovation in Biomedicine
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Annals of Dermatology

Pioneering insights into skin health and disease.
Publisher: KOREAN DERMATOLOGICAL ASSOCISSN: 1013-9087Frequency: 6 issues/year

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.